R. Hellesnes

Testicular Cancer in the Cisplatin Era: Causes of Death and Mortality Rates in a Population-Based Cohort

S. Fosså, T. Wilsgaard, R. Bremnes, 2021, Journal of Clinical Oncology.

Long-term serum platinum changes and their association with cisplatin-related late effects in testicular cancer survivors

S. Fosså, T. Wilsgaard, R. Bremnes, 2018, Acta oncologica.

Testicular Cancer in the Cisplatin Era: Causes of Death and Mortality Rates in a Population-Based Cohort

S. Fosså, T. Wilsgaard, R. Bremnes, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Continuing increased risk of second cancer in long‐term testicular cancer survivors after treatment in the cisplatin era

S. Fosså, T. Wilsgaard, R. Bremnes, 2020, International journal of cancer.

Mortality and Second Cancer Incidence After Treatment for Testicular Cancer: Psychosocial Health and Lifestyle Are Modifiable Prognostic Factors

S. Fosså, C. Kiserud, H. Haugnes, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Metachronous Contralateral Testicular Cancer in the Cisplatin Era: A Population-Based Cohort Study.

S. Fosså, T. Wilsgaard, R. Bremnes, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

708MO Metachronous contralateral testicular cancer in the cisplatin era: A population-based cohort study

S. Fosså, T. Wilsgaard, R. Bremnes, 2020 .